-
Three PK, Mirabellon will be the first imitation of Huadong Medicine
Time of Update: 2021-07-28
In October last year, Huadong Medicine reached a strategic cooperation and obtained the latter's Mirvetuximab Soravtansine's exclusive clinical development and commercialization rights in Mainland China, Hong Kong, Macau and Taiwan .
-
Centralized procurement of biopharmaceuticals is imperative, two major difficulties VS five major countermeasures
Time of Update: 2021-07-28
difficulty Clinical substitutability: the main obstacle to centralized procurement The essence of centralized procurement of drugs is to put clinically replaceable drugs together for bidding, and the lower price wins the market, thereby prompting manufacturers to quote as low prices as possible in order to realize the value pursuit of buyers .
-
Hong Kong's science and technology community has a lot to do in the country's scientific and technological self-reliance
Time of Update: 2021-07-28
He emphasized to promote the strengthening of scientific and technological cooperation between Hong Kong and the Mainland, support Hong Kong to become an international innovation and technology center, and support Hong Kong's scientific and technological community to contribute to the building of a scientific and technological power and the realization of the great rejuvenation of the Chinese nation .
-
Anti-monopoly heavy blows under control of sales are easy to "step on thunder"!
Time of Update: 2021-07-28
For example, in accordance with the "province-prefecture-county" model of sales control, a product has an ex-factory price of 10 yuan, and the retail price of a product sold to consumers is 57.
-
Health Commission: 14 newly diagnosed cases on the 26th, all imported from abroad
Time of Update: 2021-07-28
As of 24:00 on June 26, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 462 confirmed cases (including 13 severe cases), 86,634 cured and discharged cases, and 4,636 deaths.
-
31 new confirmed cases and 5 local cases were confirmed on July 18
Time of Update: 2021-07-28
As of 24:00 on July 18, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 565 confirmed cases (including 13 severe cases), 87,076 cured and discharged cases, and 4,636 deaths.
-
Experts remind to beware of "air conditioning disease" prevention is greater than cure
Time of Update: 2021-07-28
Jiang Wei, an expert in the Department of Critical Care Medicine of Shanghai Tenth People's Hospital, said in an interview on the 20th that "air-conditioning disease" is a variety of human symptoms caused by improper use of air-conditioning .
-
Health Commission: 25 newly diagnosed cases on the 25th, all imported from abroad
Time of Update: 2021-07-28
As of 24:00 on June 25, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 474 confirmed cases (including 14 severe cases), a total of 86,608 cured and discharged cases, and a total of 4,636 deaths.
-
Comparative analysis and diagnosis model establishment of membranous nephropathy and other types of nephropathy
Time of Update: 2021-07-28
The non-invasive diagnostic model established in this study through Logistic regression analysis can effectively diagnose membranous nephropathy with high sensitivity and specificity, and has a wide range of clinical application potential .
-
The adjustment of the medical insurance catalogue starts!
Time of Update: 2021-07-28
In the expert review stage, the National Medical Insurance Bureau will demonstrate the expert opinions of the professional group, and finally determine the list of drugs in five aspects: direct transfer, negotiation transfer, direct transfer, can transfer, and adjust the limited payment scope .
-
Ultra-thin spinal implants can help treat stubborn pain
Time of Update: 2021-07-28
According to a paper recently published in the journal "Science Advances", researchers at the University of Cambridge in the United Kingdom combined soft robotics manufacturing technology, ultra-thin electronics and microfluidic technology to develop an ultra-thin inflatable device that can treat the most severe limb pain , Such as leg and back pain that cannot be cured by painkillers, without the need for invasive surgery .
-
Delicious food hides "three highs" risks
Time of Update: 2021-07-28
Xu Jiao, director of the Food and Nutrition Division of the Food Safety Standards and Monitoring and Evaluation Department of the National Health Commission, said that high salt, high oil, and high sugar intake are risk factors for obesity, cardiovascular and cerebrovascular diseases, diabetes and other metabolic diseases and cancer.
-
Bicar® Pharma is registered and activated in the Drug Evaluation Center of the National Medical Products Administration as an API
Time of Update: 2021-07-28
Shanghai, 2021 Nian 4 Yue 22 Ri Solvay's pharmaceutical grade Bicar® Pharma Sodium Bicarbonate was successfully registered and activated in the Center for Drug Evaluation ( CDE ) of the National Medical Products Administration ( NMPA ) in November 2020 .
-
Hengrui Class 1 new drug is close to NDA, what signals have it released
Time of Update: 2021-07-28
Not long ago, the CDK4/6 inhibitor SHR6390 developed by Jiangsu Hengrui has been submitted to the domestic NDA for breast cancer; and 1 month ago, this product was also included in the breakthrough treatment program of CDE, and the indication was combined with fluorine.
-
Zhong Nanshan: Artificial Intelligence "Breaking Out" Helping Epidemic Prevention and Control
Time of Update: 2021-07-28
Zhong Nanshan said that the new generation of information technology such as artificial intelligence has empowered the medical, health, and public health fields, promoted the global basic medical research, clinical application research, and the research and development of pharmaceutical devices, and further enhanced human cognition and understanding of diseases .
-
Heavy: CDE has focused on clinical trials of improved new drugs for children's chemicals
Time of Update: 2021-07-28
Optimizing improved new drugs with obvious clinical advantages for children on the basis of known active ingredient drugs is a common choice for expanding children's applications.
-
Yangtze River Pharmaceutical's "Rigofinil Tablets" Launched on the First Domestic Newspaper
Time of Update: 2021-07-28
On March 24, 2013, the original CFDA approved its listing for the treatment of metastatic colorectal cancer (mCRC) that had previously received fluorouracil, oxaliplatin, and irinotecan-based chemotherapy and anti-EGFR treatment (RAS wild-type).
-
"Yangtze River Delta" VS "Pearl River Delta": Comparison of drug R&D capabilities, six highlights in the future!
Time of Update: 2021-07-28
According to the 2020 GDP performance, Guangdong Province (including the "Pearl River Delta") continues to rank first with 11 trillion yuan, which is the same as the ranking in 2015 at the beginning of the "13th Five-Year Plan" period .
-
Zhong Nanshan talks about mutant virus strains: the establishment of an immune barrier is imminent
Time of Update: 2021-07-28
"This time, due to the high viral load and highly infectious characteristics of the delta strain, as long as the patient was in the same space, unit, and building 4 days before the onset of illness, they were considered close contacts .
-
The data said: The second round of centralized procurement was implemented for one year, what impact did it bring to the market, and why did the volume and price of generic drugs fall?
Time of Update: 2021-07-28
Using the sales data analysis in 2020 (refer to the admission price of IMS), the total sales of more than 30 varieties selected in the second round of centralized procurement will be 29.
503 billion doses, and the total sales of generic drugs fell from 18.
